|

Radial vs Vena No-Touch Assessment

RECRUITINGN/ASponsored by Tomsk Cardiology Research Institute
Actively Recruiting
PhaseN/A
SponsorTomsk Cardiology Research Institute
Started2026-04-06
Est. completion2027-04
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted

Summary

This study examines the outcomes of coronary artery bypass grafting (CABG) in women at 1 year after surgery. A randomized controlled trial is planned, including a comparative analysis of two observed groups depending on the chosen conduit for revascularization of the circumflex artery. The main group is supposed to include 55 patients undergoing CABG with the use of the radial artery, while the control group will include 55 patients undergoing CABG with the use of the great saphenous vein prepared using the no-touch technique.

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

1. Three-vessel disease involving the target circumflex artery with stenosis ≥70% and a diameter ≥1.5 mm
2. Females aged 18 years and older
3. Signed informed consent
4. Clinical indications for coronary revascularization (refractory angina/transient myocardial ischemia according to noninvasive tests)

Exclusion Criteria:

1. Previous cardiac surgery of any type, including CABG
2. Combined procedures
3. Ineligibility for venous or radial artery harvesting as determined by preoperative Doppler flowmetry or clinical examination that would compromise graft patency.
4. Acute myocardial ischemia
5. EF less than 35%
6. CKD 4.5
7. Inability to understand the nature, scope, and consequences of the clinical trial, or to provide written informed consent due to cognitive impairment or mental illness.
8. Life expectancy less than 1 year due to non-cardiac diseases.

Conditions2

Coronary Artery AtherosclerosisHeart Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.